retatrutide trial results news Eli Lilly Phase 3 obesity 2026 Diabetes Dialogue: Retatrutide Reduces Body

Key Takeaways GLP-1 medications are associated with a higher risk of gallstones and gallbladder disease, and FDA labeling for Zepbound and Wegovy lists gallstones and acute cholecystitis as possible risks

Patients interested in emerging options can review comparisons like Ozempic versus retatrutide to understand how next-generation compounds might eventually expand the available choices

Symlin is currently not available on prescription on the NHS About Symlin Trade name: Symlin Generic name: Pramlinitide Drug class: Amylin analogues Manufacturer: Bristol Myers-Squibb How does Symlin help people with diabetes

Cancer / proliferation concern: Potentiating c-Met (a proto-oncogene product) raises a legitimate theoretical risk of promoting pre-existing or nascent malignancy